Latest On NantHealth, Inc (NH):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-03-06 17:18 EST | News | NantHealth to receive $22.5M in new financing from Highbridge and Nant Capital | N/A |  |
| 2022-12-15 13:28 EST | News | NantHealth executes 1-for-15 reverse stock split | N/A | |
| 2022-11-06 12:07 EST | News | NantHealth, Inc. (NH) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-04 06:11 EST | News | NantHealth Non-GAAP EPS of -$0.12, revenue of $16.6M | N/A | |
| 2022-08-07 04:24 EST | News | NantHealth, Inc. (NH) Management on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-05 05:55 EST | News | NantHealth GAAP EPS of -$0.11, revenue of $16.5M | N/A | |
| 2022-05-08 20:05 EST | News | NantHealth's (NH) Management on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-06 05:46 EST | News | NantHealth Non-GAAP EPS of -$0.11 misses by $0.02, revenue of $16.37M misses by $0.06M | N/A | |
| 2022-02-27 20:45 EST | News | NantHealth, Inc. (NH) Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-25 12:00 EST | News | NantHealth Non-GAAP EPS of -$0.10 misses by $0.01, revenue of $16M in-line | N/A | |
| 2022-02-23 23:06 EST | News | NantHealth Q4 2021 Earnings Preview | N/A | |
| 2021-11-05 10:44 EST | News | NantHealth EPS misses by $0.02, misses on revenue | N/A | |
| 2021-11-02 01:12 EST | News | Warning: NH is at high risk of performing badly | N/A | |
| 2021-08-06 07:47 EST | News | NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-03 15:47 EST | News | NantHealth picks internal candidate for medical chief | N/A | |
| 2021-04-14 11:31 EST | News | NantHealth to issue $137.5M of senior unsecured convertible notes due 2026 | N/A | |
| 2021-03-01 16:02 EST | Earnings Estimate | An EPS average of -$0.06 is estimated for the quarter ending on June 30, 2021. | N/A | |
| 2021-03-01 16:02 EST | Earnings Estimate | An EPS average of -$0.17 is estimated for the 2022 year. | Sell | |
| 2021-02-27 16:42 EST | News | NantHealth, Inc. (NH) Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-27 00:17 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-25 20:17 EST | News | NantHealth and Sesame sign deal to offer patients direct access to affordable care | N/A | |
| 2020-12-12 03:05 EST | News | NantHealth jumps after study highlights the utility of its decision-support platform | N/A | |
| 2020-11-26 20:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 04:46 EST | Analyst Rating | The Analyst Target Price has decreased from $4.25 to $3.75. | Neutral | |
| 2020-11-11 04:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 04:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 04:41 EST | Earnings Estimate | An EPS average of -$0.05 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-08 11:32 EST | News | NantHealth, Inc. (NH) Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 00:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 14:54 EST | News | NantHealth EPS in-line, beats on revenue | N/A | |
| 2020-09-26 13:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 09:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-11 21:28 EST | Analyst Rating | The Analyst Target Price has increased from $3.3 to $4.25. | Buy | |
| 2020-08-11 01:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-09 19:48 EST | News | NantHealth, Inc. (NH) Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-08 01:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 23:04 EST | News | NantHealth EPS misses by $0.01, misses on revenue | N/A | |
| 2020-08-06 21:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 13:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 01:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 05:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-10 19:29 EST | News | NantHealth Points To The Future Of Healthcare | N/A | |
| 2020-07-09 09:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 17:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-26 09:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 05:11 EST | Financials | Company financials have been released. | Neutral | |
About NantHealth, Inc (NH):
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
General
- Name NantHealth, Inc
- Symbol NH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryHealth Information Services
- Full Time Employees 352
- Fiscal Year EndDecember
- IPO Date2016-06-02
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Technology
- Gic SubIndustryHealth Care Technology
- Web URLhttp://nanthealth.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 5.67
- Enterprise Value Revenue 8.43
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.29
- Next Year EPS Estimate -$0.21
- Next Quarter EPS Estimate -$0.07
- Profit Margin -77%
- Operating Margin -35%
- Return on Assets -7%
- Revenue 73.17 million
- Earnings Per Share -$1.65
- Revenue Per Share $0.66
- Gross Profit 48.7 million
- Quarterly Earnings Growth 0.4%
View More
Highlights
- Market Capitalization 401.86 million
- EBITDA -27742000
- Analyst Target Price $3.75
- Book Value Per Share -$0.28
View More
Share Statistics
- Shares Outstanding 111.32 million
- Shares Float 27.46 million
- % Held by Insiders 5962%
- % Held by Institutions 21.64%
- Shares Short 1.81 million
- Shares Short Prior Month 1.86 million
- Short Ratio 2.3
- Short % of Float 7%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.75
- 52 Week High $6.39
- 52 Week Low $1.18
- 50 Day Moving Average 4.16
- 200 Day Moving Average 3.07
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
NantHealth, Inc (NH) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
NantHealth, Inc (NH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$0.06 | -$0.08 | 25% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.07 | -$0.07 | -7.69% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.07 | -$0.06 | -27.27% |
| 2020-03-31 | 2020-05-07 | $18.18 million | -$0.06 | -$0.07 | 7.69% |
| 2019-12-31 | 2020-02-28 | $24.19 million | -$0.04 | -$0.06 | 27.27% |
| 2019-09-30 | 2019-11-07 | $22.36 million | -$0.07 | -$0.04 | -100% |
| 2019-06-30 | 2019-08-08 | $25.69 million | -$0.04 | -$0.09 | 55.56% |
| 2019-03-31 | 2019-05-09 | $23.73 million | -$0.10 | -$0.10 | 0% |
| 2018-12-31 | 2019-03-28 | $22.86 million | -$0.08 | -$0.09 | 11.11% |
| 2018-09-30 | 2018-11-15 | $22.29 million | -$0.10 | -$0.13 | 20% |
| 2018-06-30 | 2018-08-09 | $22.05 million | -$0.10 | -$0.11 | 9.09% |
| 2018-03-31 | 2018-05-09 | $22.26 million | -$0.12 | -$0.12 | -4.35% |
| 2017-12-31 | 2018-03-14 | $22.3 million | -$0.07 | -$0.14 | 51.15% |
| 2017-09-30 | 2017-11-09 | $21.76 million | -$0.13 | -$0.14 | 3.7% |
| 2017-06-30 | 2017-08-10 | $23.51 million | -$0.18 | -$0.16 | -10.77% |
| 2017-03-31 | 2017-05-10 | $19.1 million | -$0.24 | -$0.20 | -23.08% |
| 2016-12-31 | 2017-03-30 | $17.85 million | -$0.18 | -$0.19 | 6.1% |
| 2016-09-30 | 2016-11-07 | $20.66 million | -$0.18 | -$0.21 | 15.09% |
| 2016-06-30 | 2016-08-09 | $22.45 million | -$0.15 | -$0.41 | 63.19% |
NantHealth, Inc (NH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
NantHealth, Inc (NH) Chart:
NantHealth, Inc (NH) News:
Below you will find a list of latest news for NantHealth, Inc (NH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
NantHealth, Inc (NH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest NH Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:57 PM EST | 100 | $0.545 |
| Jun 13, 2022 7:58 PM EST | 100 | $0.5447 |
| Jun 13, 2022 7:58 PM EST | 44 | $0.5447 |
| Jun 13, 2022 7:58 PM EST | 3 | $0.54 |
| Jun 13, 2022 7:59 PM EST | 24 | $0.5416 |
NantHealth, Inc (NH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000032/0001566469-20-000032-index.htm |
| 2017-08-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1566469/000000000017028146/0000000000-17-028146-index.htm |
| 2018-03-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1566469/000000000018009095/0000000000-18-009095-index.htm |
| 2017-08-25 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317021040/0000899243-17-021040-index.htm |
| 2017-08-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317021042/0000899243-17-021042-index.htm |
| 2017-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317023695/0000899243-17-023695-index.htm |
| 2017-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317023972/0000899243-17-023972-index.htm |
| 2017-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025608/0000899243-17-025608-index.htm |
| 2017-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025615/0000899243-17-025615-index.htm |
| 2017-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025617/0000899243-17-025617-index.htm |
| 2017-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm |
| 2017-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924317028187/0000899243-17-028187-index.htm |
| 2018-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318000825/0000899243-18-000825-index.htm |
| 2018-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318003102/0000899243-18-003102-index.htm |
| 2018-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318006835/0000899243-18-006835-index.htm |
| 2018-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318009869/0000899243-18-009869-index.htm |
| 2018-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318011409/0000899243-18-011409-index.htm |
| 2018-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318011410/0000899243-18-011410-index.htm |
| 2018-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318011837/0000899243-18-011837-index.htm |
| 2018-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318015564/0000899243-18-015564-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318015994/0000899243-18-015994-index.htm |
| 2018-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318019699/0000899243-18-019699-index.htm |
| 2018-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318021603/0000899243-18-021603-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024008/0000899243-18-024008-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024009/0000899243-18-024009-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024013/0000899243-18-024013-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024014/0000899243-18-024014-index.htm |
| 2018-09-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024913/0000899243-18-024913-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924318026470/0000899243-18-026470-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924319012058/0000899243-19-012058-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924319017240/0000899243-19-017240-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924319017241/0000899243-19-017241-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924319017243/0000899243-19-017243-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924319021724/0000899243-19-021724-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924319021726/0000899243-19-021726-index.htm |
| 2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924319026921/0000899243-19-026921-index.htm |
| 2020-03-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320008304/0000899243-20-008304-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320008306/0000899243-20-008306-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320012104/0000899243-20-012104-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320014193/0000899243-20-014193-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320014199/0000899243-20-014199-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320014203/0000899243-20-014203-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320023104/0000899243-20-023104-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1566469/000089924320023105/0000899243-20-023105-index.htm |
| 2017-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000119312517252742/0001193125-17-252742-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1566469/000119312518045791/0001193125-18-045791-index.htm |
| 2018-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000119312518077306/0001193125-18-077306-index.htm |
| 2018-03-16 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1566469/000119312518086060/0001193125-18-086060-index.htm |
| 2018-04-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1566469/000119312518104529/0001193125-18-104529-index.htm |
| 2018-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1566469/000119312518143057/0001193125-18-143057-index.htm |
| 2018-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000119312518189508/0001193125-18-189508-index.htm |
| 2018-06-15 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1566469/000119312518194503/0001193125-18-194503-index.htm |
| 2018-07-11 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000119312518216117/0001193125-18-216117-index.htm |
| 2018-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000119312518256401/0001193125-18-256401-index.htm |
| 2018-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000119312518271335/0001193125-18-271335-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1566469/000119312519129241/0001193125-19-129241-index.htm |
| 2020-04-21 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1566469/000119312520112644/0001193125-20-112644-index.htm |
| 2017-07-31 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1566469/000156646917000021/0001566469-17-000021-index.htm |
| 2017-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646917000024/0001566469-17-000024-index.htm |
| 2017-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646917000027/0001566469-17-000027-index.htm |
| 2017-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646917000031/0001566469-17-000031-index.htm |
| 2017-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646917000035/0001566469-17-000035-index.htm |
| 2017-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646917000038/0001566469-17-000038-index.htm |
| 2018-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000003/0001566469-18-000003-index.htm |
| 2018-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000006/0001566469-18-000006-index.htm |
| 2018-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000008/0001566469-18-000008-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000010/0001566469-18-000010-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000014/0001566469-18-000014-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000017/0001566469-18-000017-index.htm |
| 2018-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000022/0001566469-18-000022-index.htm |
| 2018-11-21 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646918000026/0001566469-18-000026-index.htm |
| 2019-01-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000003/0001566469-19-000003-index.htm |
| 2019-03-18 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000006/0001566469-19-000006-index.htm |
| 2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000009/0001566469-19-000009-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000012/0001566469-19-000012-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000015/0001566469-19-000015-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000021/0001566469-19-000021-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000023/0001566469-19-000023-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000024/0001566469-19-000024-index.htm |
| 2019-05-31 | SD | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000028/0001566469-19-000028-index.htm | |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000031/0001566469-19-000031-index.htm |
| 2019-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000034/0001566469-19-000034-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000040/0001566469-19-000040-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000042/0001566469-19-000042-index.htm |
| 2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000045/0001566469-19-000045-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000050/0001566469-19-000050-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000054/0001566469-19-000054-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646919000055/0001566469-19-000055-index.htm |
| 2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000004/0001566469-20-000004-index.htm |
| 2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000006/0001566469-20-000006-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000013/0001566469-20-000013-index.htm |
| 2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000015/0001566469-20-000015-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000017/0001566469-20-000017-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000021/0001566469-20-000021-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000023/0001566469-20-000023-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000025/0001566469-20-000025-index.htm |
| 2020-05-29 | SD | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000028/0001566469-20-000028-index.htm | |
| 2020-06-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000032/0001566469-20-000032-index.htm |
| 2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000035/0001566469-20-000035-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000039/0001566469-20-000039-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000042/0001566469-20-000042-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1566469/000156646920000048/0001566469-20-000048-index.htm |
| 2018-04-04 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1566469/999999999518000756/9999999995-18-000756-index.htm |
| 2018-03-23 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1566469/999999999718003638/9999999997-18-003638-index.htm |
NantHealth, Inc (NH) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NantHealth, Inc (NH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 5962%Institutional Ownership: 2164%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2017-10-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 26,820.00 | 4.28 | 114,789.60 | 0.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317023972/0000899243-17-023972-index.htm |
| 2017-11-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm | ||
| 2017-11-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 125,196.00 | 131,901.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm | ||
| 2018-09-06 | KIRK K CALHOUN | Director | Buy | 52,910.00 | 148,780.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024008/0000899243-18-024008-index.htm | ||
| 2018-09-06 | MICHAEL D BLASZYK | Director | Buy | 52,910.00 | 148,780.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024013/0000899243-18-024013-index.htm | ||
| 2018-09-06 | MICHAEL S SITRICK | Director | Buy | 52,910.00 | 148,780.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024014/0000899243-18-024014-index.htm | ||
| 2018-05-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 7,005.00 | 3.41 | 23,887.05 | 167,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318011837/0000899243-18-011837-index.htm |
| 2018-06-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 5,604.00 | 3.49 | 19,557.96 | 167,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318015564/0000899243-18-015564-index.htm |
| 2018-07-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 5,749.00 | 3.54 | 20,351.46 | 167,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318019699/0000899243-18-019699-index.htm |
| 2018-08-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 6,304.00 | 3.15 | 19,857.60 | 167,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318021603/0000899243-18-021603-index.htm |
| 2018-09-06 | Ronald Allen Louks | Officer | Sell | 6,305.00 | 1.89 | 11,916.45 | 167,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024009/0000899243-18-024009-index.htm |
| 2018-10-06 | Ronald Allen Louks | Officer | Sell | 6,304.00 | 1.42 | 8,951.68 | 167,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318026470/0000899243-18-026470-index.htm |
| 2018-05-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 177,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318011837/0000899243-18-011837-index.htm | ||
| 2018-06-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 177,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318015564/0000899243-18-015564-index.htm | ||
| 2018-07-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 177,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318019699/0000899243-18-019699-index.htm | ||
| 2018-08-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 177,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318021603/0000899243-18-021603-index.htm | ||
| 2018-09-06 | Ronald Allen Louks | Officer | Buy | 10,000.00 | 177,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024009/0000899243-18-024009-index.htm | ||
| 2018-10-06 | Ronald Allen Louks | Officer | Buy | 10,000.00 | 177,391.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318026470/0000899243-18-026470-index.htm | ||
| 2020-03-11 | Deanna L. Wise | Director | Buy | 179,558.00 | 179,558.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924320008306/0000899243-20-008306-index.htm | ||
| 2018-05-01 | Ronald Allen Louks | Chief Operating Officer | Buy | 125,196.00 | 204,886.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318011409/0000899243-18-011409-index.htm | ||
| 2019-05-01 | Ronald Allen Louks | Chief Operating Officer | Buy | 125,196.00 | 292,587.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924319012058/0000899243-19-012058-index.htm | ||
| 2020-05-01 | Ronald Allen Louks | Chief Operating Officer | Buy | 125,195.00 | 361,818.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924320012104/0000899243-20-012104-index.htm | ||
| 2017-10-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 40,000.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317023972/0000899243-17-023972-index.htm | ||
| 2017-05-01 | PAUL HOLT | Chief Financial Officer | Buy | 3,974.00 | 45,474.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317021042/0000899243-17-021042-index.htm | ||
| 2017-11-06 | KIRK K CALHOUN | Director | Buy | 50,868.00 | 50,868.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025615/0000899243-17-025615-index.htm | ||
| 2017-11-06 | MICHAEL D BLASZYK | Director | Buy | 50,868.00 | 50,868.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025617/0000899243-17-025617-index.htm | ||
| 2017-11-06 | MICHAEL S SITRICK | Director | Buy | 50,868.00 | 50,868.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025608/0000899243-17-025608-index.htm | ||
| 2018-05-01 | PAUL HOLT | Chief Financial Officer | Buy | 3,974.00 | 56,822.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318011410/0000899243-18-011410-index.htm | ||
| 2017-06-07 | PAUL HOLT | Chief Financial Officer | Buy | 14,207.00 | 58,187.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317021042/0000899243-17-021042-index.htm | ||
| 2018-06-07 | PAUL HOLT | Chief Financial Officer | Buy | 14,207.00 | 69,655.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318015994/0000899243-18-015994-index.htm | ||
| 2017-11-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 6,705.00 | 3.39 | 22,729.95 | 79,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm |
| 2017-12-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 5,245.00 | 3.03 | 15,892.35 | 79,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317028187/0000899243-17-028187-index.htm |
| 2018-01-08 | Ronald Allen Louks | Chief Operating Officer | Sell | 6,175.00 | 3.52 | 21,736.00 | 79,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318000825/0000899243-18-000825-index.htm |
| 2018-02-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 6,475.00 | 3.02 | 19,554.50 | 79,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318003102/0000899243-18-003102-index.htm |
| 2018-03-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 7,095.00 | 3.56 | 25,258.20 | 79,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318006835/0000899243-18-006835-index.htm |
| 2018-04-06 | Ronald Allen Louks | Chief Operating Officer | Sell | 7,005.00 | 3.04 | 21,295.20 | 79,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318009869/0000899243-18-009869-index.htm |
| 2017-12-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 89,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924317028187/0000899243-17-028187-index.htm | ||
| 2018-01-08 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 89,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318000825/0000899243-18-000825-index.htm | ||
| 2018-02-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 89,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318003102/0000899243-18-003102-index.htm | ||
| 2018-03-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 89,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318006835/0000899243-18-006835-index.htm | ||
| 2018-04-06 | Ronald Allen Louks | Chief Operating Officer | Buy | 10,000.00 | 89,690.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318009869/0000899243-18-009869-index.htm | ||
| 2018-09-06 | KIRK K CALHOUN | Director | Buy | 45,002.00 | 95,870.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024008/0000899243-18-024008-index.htm | ||
| 2018-09-06 | MICHAEL D BLASZYK | Director | Buy | 45,002.00 | 95,870.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024013/0000899243-18-024013-index.htm | ||
| 2018-09-06 | MICHAEL S SITRICK | Director | Buy | 45,002.00 | 95,870.00 | https://www.sec.gov/Archives/edgar/data/1566469/000089924318024014/0000899243-18-024014-index.htm |